GlaxoSmithKline will award a total of $250,000 for innovative HIV/AIDS treatment, vaccine, or microbicide drug discovery and development research (from $25,000 to $150,000 for each grant). Researchers must submit applications by July 31, 2004 and the grants will be paid on December 1. There is no obligation to license resulting technology to the company.

In the previous three years of the program, GSK has awarded $1.25 million to 14 researchers.

For more information about the GSK Drug Discovery and Development Research Grant Program, and for an application, call 1-888-527-6935 or visit www.dddresearchgrant.com.

ISSN # 1052-4207

Advertisement

Copyright 2004 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.